XW003 injection

DRUG5 trials

Sponsors

Hangzhou Sciwind Biosciences Co., Ltd.

Conditions

Healthy VolunteersOSA - Obstructive Sleep ApneaObese AdolescentsObesityWeight Management

Phase 1

A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin

CompletedNCT06335134

Hangzhou Sciwind Biosciences Co., Ltd.Healthy Volunteers

Start: 2023-07-14End: 2024-06-28Updated: 2025-05-08

A Study of XW003 Injection in Chinese Adolescents With Obesity

RecruitingNCT07143227

Hangzhou Sciwind Biosciences Co., Ltd.Obese Adolescents, Obesity

Start: 2025-08-25End: 2026-12-31Target: 48Updated: 2026-01-28

Phase 2

A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)

RecruitingNCT07073417

Hangzhou Sciwind Biosciences Co., Ltd.Obesity, Weight Management

Start: 2025-07-28End: 2027-08-23Target: 160Updated: 2025-08-20

Phase 3

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy

Not yet recruitingNCT07387094

Hangzhou Sciwind Biosciences Co., Ltd.Obesity, OSA - Obstructive Sleep Apnea

Start: 2026-03-03End: 2027-12-16Target: 140Updated: 2026-02-04

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy

Not yet recruitingNCT07434050

Hangzhou Sciwind Biosciences Co., Ltd.Obesity, OSA - Obstructive Sleep Apnea

Start: 2026-03-09End: 2028-06-19Target: 140Updated: 2026-02-25